Jason Lief is a premier patent trial lawyer with 25 years of experience. He has litigated and tried dozens of major patent and other intellectual property cases on behalf of some of the world’s most innovative and dynamic companies, often involving billion dollar products. Applying his legal and scientific training, Jason has established a reputation for winning outcomes and courtroom excellence.

Max Yusem is an of counsel in the Litigation practice of Paul Hastings and is based in the firm’s New York office. His practice focuses on complex litigation with an emphasis on intellectual property matters in the fields of pharmaceuticals and biotechnology.

Mr. Yusem has experience litigating cases arising under the Hatch-Waxman Act on behalf of innovator companies and the Biologics Price Competition and Innovation Act (BPCIA). He has represented leading life science companies in high-stakes disputes in district court litigations, patent office proceedings, and arbitrations involving pharmaceutical compounds, formulations, and methods of treatment, which involved a wide variety of therapeutics, covering areas such as cardiovascular, diabetes, oncology, central and peripheral nervous systems, hormone replacement, and hemoglobinopathy.

Mr. Yusem has also consulted and represented clients in numerous other areas including antibody technology, genetic testing, microfluidic devices, and ethanol processing. He received his law degree, with honors, from George Washington University School of Law in 2013, where he served on the George Washington International Law Review. He earned a Bachelor of Arts from the Department of Psychological and Brain Sciences at Johns Hopkins University in 2008. Mr. Yusem is admitted to the New York State Bar.